Slideset: Hepatitis B Screening, Diagnosis, and Treatment Candidacy
Source: Understanding and Implementing the AASLD’s HBV Practice Guidelines and Other Recent Guidelines and Recommendations on the Diagnosis, Management, and Treatment of Hepatitis B


Slideset: Hepatitis B Screening, Diagnosis, and Treatment Candidacy

In this downloadable slideset, Kris V. Kowdley, MD, FACP, FACG, FASGE, AGAF, reviews the latest guideline recommendations on HBV screening, diagnosis, and treatment candidacy.
Format: Microsoft PowerPoint (.ppt)
File size: 5.78 MB
Date posted: 11/11/2010
  • The Age-Old Debate of Whether to Biopsy in HCV: My Answer for 2013

    Mark S. Sulkowski MD - 1/23/2013    17 comments / Last Comment: 11/2/2013
    With interferon-free, all-oral therapies on the near-term horizon, I am increasingly comfortable relying on patient history, physical exam, routine laboratory tests, and liver imaging as well as noninvasive serum markers to obtain a picture of liver health.
  • Time to Change Our Management Approach in HBV-Immunotolerant Patients?

    Graham R. Foster FRCP, PhD - 1/4/2013    46 comments / Last Comment: 2/27/2014
    New data suggesting that young adults with hepatitis B who have “immunotolerant” disease may actually have very active immune responses raise difficult questions about when to initiate therapy.
  • Coffee May Offer Real Benefits to the Liver

    Mark S. Sulkowski MD - 8/13/2013    7 comments / Last Comment: 11/30/2013
    The latest prescription for liver health in patients with hepatitis: coffee.
  • A New Tool for HCV Patients With Low Platelet Counts

    Raymond T. Chung MD - 1/7/2013    18 comments / Last Comment: 5/12/2013
    Although the use of a platelet-boosting agent will assist certain subsets of patients who cannot wait for the approval of direct-acting antivirals, we can envision that the need for such a strategy will steadily wane over time.